Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bruton Tyrosine Kinase Inhibitor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02328014
What this trial is testing

Acalabrutinib (ACP-196) in Combination With ACP-319, for Treatment of B-Cell Malignancies

Who this might be right for
Non-Hodgkins LymphomaMultiple MyelomaB-All
Acerta Pharma BV 40
Testing effectiveness (Phase 2)WithdrawnNCT04148742
What this trial is testing

Assessing an Oral Bruton Tyrosine Kinase Inhibitor, DZD9008 in Patients Who Have Non-Hodgkin B-cell Lymphoma (WU-KONG3)

Who this might be right for
Non-Hodgkin's B-cell Lymphoma
Dizal Pharmaceuticals
Testing effectiveness (Phase 2)Ended earlyNCT05356858
What this trial is testing

An Open Label Study of the Effects and Safety of Zanubrutinib in NMOSDs Adult Patients

Who this might be right for
Neuromyelitis Optica
Xuanwu Hospital, Beijing 6
Testing effectiveness (Phase 2)Study completedNCT02760485
What this trial is testing

Itacitinib (INCB039110) in Combination With Ibrutinib in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Who this might be right for
Lymphoma
Incyte Corporation 33
Large-scale testing (Phase 3)Study completedNCT01973387
What this trial is testing

PCI-32765 (Ibrutinib) Versus Rituximab in Relapsed or Refractory Chronic Leukemia/Lymphoma

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Janssen Research & Development, LLC 160
Early research (Phase 1)Ended earlyNCT03671590
What this trial is testing

Study of TG-1701, an Irreversible Bruton's Tyrosine Kinase Inhibitor, in Patients With B-Cell Malignancies

Who this might be right for
Non Hodgkin LymphomaChronic Lymphocytic Leukemia
TG Therapeutics, Inc. 172
Early research (Phase 1)Looking for participantsNCT05990465
What this trial is testing

LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies

Who this might be right for
Non Hodgkin LymphomaDiffuse Large B Cell LymphomaFollicular Lymphoma+3 more
Medical College of Wisconsin 12
Early research (Phase 1)Study completedNCT02211014
What this trial is testing

An Open-Label, Phase 1b Study of Acalabrutinib With and Without Dexamethasone in Subjects With Multiple Myeloma

Who this might be right for
Multiple Myeloma (MM)
Acerta Pharma BV 27
Testing effectiveness (Phase 2)Looking for participantsNCT06520098
What this trial is testing

Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
VA Office of Research and Development 100
Early research (Phase 1)Ended earlyNCT02292225
What this trial is testing

Duvelisib With Obinutuzumab in Patients With CLL/SLL Previously Treated With a BTKi (SYNCHRONY)

Who this might be right for
Lymphocytic Leukemia, ChronicLymphoma, Small Lymphocytic
SecuraBio 3
Testing effectiveness (Phase 2)Study completedNCT04116437
What this trial is testing

Zanubrutinib (BGB-3111) in Participants With Previously Treated B-Cell Lymphoma Intolerant of Prior Bruton Tyrosine Kinase Inhibitor (BTKi) Treatment

Who this might be right for
Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaMantle Cell LymphomaMarginal Zone Lymphoma+1 more
BeiGene 96
Not applicableStudy completedNCT05621148
What this trial is testing

REfractorinesS to Ibrutinib BTKi and Systemic Targeted Therapy

Who this might be right for
CLL, RelapsedCLL, RefractoryBruton Tyrosine Kinase Inhibitor+1 more
French Innovative Leukemia Organisation 152
Testing effectiveness (Phase 2)Looking for participantsNCT06588478
What this trial is testing

A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Loxo Oncology, Inc. 249
Testing effectiveness (Phase 2)Looking for participantsNCT03328078
What this trial is testing

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

Who this might be right for
Relapsed Hematologic MalignancyRefractory Hematologic MalignancyRelapsed Primary Central Nervous System Lymphoma+1 more
Curis, Inc. 152
Large-scale testing (Phase 3)Looking for participantsNCT07277231
What this trial is testing

Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
BeOne Medicines 500
Testing effectiveness (Phase 2)Study completedNCT03332173
What this trial is testing

Study of BTK Inhibitor BGB-3111 in Chinese Subjects With Relapsed/Refractory Waldenström's Macroglobulinemia (WM)

Who this might be right for
Waldenström's Macroglobulinemia (WM)
BeiGene 44
Testing effectiveness (Phase 2)Active Not RecruitingNCT04014205
What this trial is testing

Tyrosine Kinase Inhibitor Orelabrutinib (ICP-022) in Patients With r/r B-Cell Malignancies

Who this might be right for
Part 1：r/r B-cell MalignanciesPart 2：B-cell Malignancies
Beijing InnoCare Pharma Tech Co., Ltd. 81
Testing effectiveness (Phase 2)Looking for participantsNCT06333262
What this trial is testing

Fixed Duration Pirtobrutinib and Obinutuzumab in Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Inhye Ahn 60
Early research (Phase 1)Study completedNCT02419560
What this trial is testing

Optimal Dose Finding Study ABT-199 and Ibrutinib in MCL

Who this might be right for
Lymphoma, Mantle-CellRecurrent Lymphoma, Mantle-Cell
Craig Portell, MD 37
Testing effectiveness (Phase 2)Study completedNCT03323151
What this trial is testing

Ixazomib and Ibrutinib in Relapsed/Refractory Mantle Cell Lymphoma

Who this might be right for
Mantle-Cell Lymphoma
PrECOG, LLC. 43
Next Page